Where the Old Risk Model Still Quietly Runs the Industry
Academics have spent decades documenting where CAPM's predictions break down, yet the model never left the building. It still sets the discount rate behind nearly every corporate valuation and the benchmark behind nearly every fund's reported alpha, which means understanding it is not optional if you want to interpret the numbers the industry hands you.
Why a criticized model never got replaced
It is a genuine puzzle, on the surface, that CAPM remains the default tool across corporate finance and fund evaluation despite the empirical record described elsewhere in this series. The answer is mostly practical rather than theoretical. CAPM needs only three inputs, a risk-free rate, a market risk premium, and a single beta, all of which are cheap and fast to estimate from widely available data. Multifactor alternatives require estimating several factor premiums and several factor betas, each with its own estimation error, and reasonable practitioners can disagree meaningfully about which factors even belong in the model. In an industry that produces thousands of valuations and performance reports every day, a simple, standardized, defensible method tends to beat a marginally more accurate but harder-to-agree-upon one, and CAPM's single-number simplicity has made it the industry's common language even among professionals who know its limitations well.
There is also a legal and procedural dimension that reinforces CAPM's staying power. Courts, regulators, and arbitration panels handling disputes over fair value, in shareholder litigation, minority buyouts, or utility rate cases, for instance, need a discount rate methodology that is well documented, widely taught, and defensible under cross-examination. CAPM's decades-long academic paper trail and its presence in essentially every finance curriculum and professional certification syllabus make it the default choice in these settings, not because it is provably the most accurate model available, but because its assumptions and mechanics can be explained, checked, and disputed using a shared, well-established vocabulary that all parties in a dispute already know.
Setting the cost of equity capital
The single largest practical use of CAPM is estimating a company's cost of equity, the return shareholders require for holding the company's stock, which becomes the discount rate applied to the equity portion of a discounted cash flow valuation. The formula is unchanged from the portfolio-theory version: cost of equity = risk-free rate + beta × market risk premium. That cost of equity then typically combines with a company's after-tax cost of debt, weighted by the proportion of equity and debt in its capital structure, to produce the weighted average cost of capital, or WACC, the single discount rate used to value the entire enterprise, not just the shares.
Because this discount rate compounds over many years of projected cash flows, small changes in the beta assumption can move a valuation by a large amount, a sensitivity every analyst learns to respect early in their career.
In practice, analysts rarely use a raw, unadjusted regression beta. Data providers such as major financial data terminals typically publish an adjusted beta, which pulls the raw statistical estimate part of the way back toward 1.0 using a simple weighting formula, commonly two-thirds the raw beta plus one-third times 1.0, reflecting the empirical tendency of extreme betas to drift toward the market average over time. Analysts working on private companies or specific divisions of a larger firm face an additional complication, since no directly observable stock price and therefore no directly regressable beta exists; the standard workaround, called the pure-play method, borrows betas from publicly traded companies in a similar business, then adjusts for differences in financial leverage between the comparison companies and the subject business, a multi-step process that introduces its own layer of judgment and potential error on top of CAPM's own.
A discounted cash flow, worked through
Consider a mature industrial company expected to generate free cash flow to equity of $120 million next year, growing at a stable 3% per year indefinitely thereafter. With a risk-free rate of 4%, a market risk premium of 5.5%, and an estimated beta of 1.0, the cost of equity is 4% + 1.0 × 5.5% = 9.5%. Using the standard growing perpetuity formula, value = cash flow / (discount rate - growth rate), the equity value comes to $120 million / (9.5% - 3%) = $120 million / 0.065 = $1.846 billion.
Now suppose a more careful analysis, incorporating the company's actual debt load and business cyclicality, raises the beta estimate to 1.3 instead. The cost of equity rises to 4% + 1.3 × 5.5% = 11.15%, and the same cash flow stream is now worth $120 million / (11.15% - 3%) = $120 million / 0.0815 = $1.472 billion. A beta revision of only 0.3 changed the estimated value by roughly $374 million, a swing of about 20%, illustrating why beta assumptions in professional valuations deserve as much scrutiny as the cash flow forecasts themselves, if not more.
Judging fund manager performance
The second major industry application is performance evaluation. When a fund reports beating its benchmark, the natural next question is whether that outperformance reflects genuine skill or simply a higher level of market risk than the benchmark itself carried. Jensen's alpha, developed by Michael Jensen in 1968, answers this using CAPM directly: it compares a fund's actual realized return against the return CAPM would have predicted given the fund's own beta, with the difference, positive or negative, labeled alpha. A fund manager who takes on more market risk than the benchmark should be expected, by CAPM's own logic, to earn a higher raw return without that extra return implying any skill at all; alpha strips this effect out.
A closely related but distinct measure, the Treynor ratio, divides a portfolio's excess return over the risk-free rate by its beta rather than by its total standard deviation, the denominator used in the more familiar Sharpe ratio. The distinction matters for a specific reason: the Treynor ratio is the appropriate tool when evaluating one holding as part of a larger, already diversified portfolio, since it only penalizes systematic risk, the kind that cannot be diversified away, while the Sharpe ratio penalizes total risk and is more appropriate when judging a portfolio, or a fund, that represents an investor's entire holdings. Using the wrong one, applying a Sharpe ratio to judge a single satellite holding inside an otherwise diversified portfolio, for instance, can penalize a position for firm-specific volatility that the rest of the portfolio has already diversified away and therefore should not be counted against it.
Computing Jensen's alpha, worked through
Suppose a fund returned 11% over the past year, while the risk-free rate averaged 4% and the broad market returned 9%, a market risk premium of 9% - 4% = 5%. The fund's estimated beta, from a regression of its historical returns against the market, is 1.2. CAPM's predicted return for a portfolio with that beta is 4% + 1.2 × 5% = 4% + 6% = 10%. Jensen's alpha is the fund's actual return minus this predicted figure: 11% - 10% = 1%, meaning the manager delivered one percentage point of return beyond what their level of market risk alone would explain.
Now compare a second fund that also returned 11%, but with a beta of 1.6 instead. Its CAPM-predicted return is 4% + 1.6 × 5% = 4% + 8% = 12%, so its alpha is 11% - 12% = -1%, a negative figure, despite posting the same headline return as the first fund. The second fund actually underperformed what its higher risk level should have delivered; its seemingly identical raw return was masking worse risk-adjusted performance.
Reading these numbers as an investor
When you encounter a "beat the market" claim in a fund's marketing material, the useful habit is to ask what beta the fund actually carried during the period being cited, since a fund holding higher-beta, more volatile stocks will tend to post higher raw returns during a rising market almost automatically, with no skill required at all. This is precisely why fund marketing materials so often highlight raw return during strong bull markets and pivot toward downside-protection language during and after a decline; the underlying beta of the portfolio rarely changed, but which framing flatters that beta shifted with the market environment. The same logic applies in reverse during a market decline, where a low-beta fund's smaller losses are not necessarily evidence of defensive skill either. Cost-of-capital assumptions matter just as much when reading equity research: a price target built on an unusually low beta assumption is, in effect, using an unusually low discount rate to justify an unusually high valuation, and a careful reader checks that assumption before trusting the conclusion. The same scrutiny applies in reverse when a bearish analyst wants to justify a low price target: an inflated beta assumption pushes the discount rate up and the resulting valuation down, without the analyst needing to change a single cash flow forecast to arrive at a dramatically more negative conclusion.
Actionable breakdown
- Interrogate the beta behind any valuation you are shown.
- A small beta change can shift a valuation by 15% or more.
- Ask what risk-free rate and market premium were assumed.
- Read "alpha" as risk-adjusted, not raw, outperformance.
- Check the fund's beta before comparing its alpha to another fund's.
- Remember alpha from one strong year rarely predicts the next.
- Treat WACC-based valuations as sensitivity ranges, not single numbers.
- Re-run the math with a beta 0.2 to 0.3 higher and lower.
Common pitfalls
A common mistake is accepting a company's stated cost of capital at face value without checking whether the beta and risk premium behind it are current and reasonable, since these assumptions are easy to quietly adjust to support a predetermined valuation conclusion. Another is comparing two funds' alpha figures that were computed using different benchmarks or different lookback periods, which makes the comparison meaningless even though both numbers are technically labeled the same way. A third pitfall is assuming a single year of positive alpha demonstrates repeatable manager skill, when a large body of research on mutual fund performance persistence finds that outperformance in one period predicts remarkably little about the next. A fourth, more subtle pitfall is confusing a Treynor ratio with a Sharpe ratio when the two are labeled simply as risk-adjusted return without specifying which denominator was used, since a portfolio can rank favorably under one measure and unfavorably under the other, particularly when it holds a meaningful amount of diversifiable, firm-specific risk that a beta-only measure would not penalize.
The bottom line
CAPM's academic imperfections have not dislodged it from daily practice, because it remains the fastest common language for pricing risk in valuations and for separating genuine manager skill from risk taken and rewarded automatically by the market.
Related reading: valuation ratios, stock analysis, the core CAPM formula and mechanism, how academics have tested and challenged CAPM, the conventional theory of performance evaluation.